# Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD

> **NCT04027712** · — · UNKNOWN · sponsor: **University of Athens** · enrollment: 120 (estimated)

## Conditions studied

- Diabetes
- Clopidogrel Resistance
- Amyloid
- Insulin Resistance

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04027712
- **Lead sponsor:** University of Athens
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2019-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04027712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04027712, "Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04027712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*